Ismail H, Alzubaidi FA, Oubaid EN. Targeting the IL-33/ST2 signalling pathway as a therapeutic strategy for the treatment of multiple inflammatory diseases. P [Internet]. 2025 Oct. 10 [cited 2025 Oct. 11];37(2S). Available from: https://pharmakeftiki.hsmc.gr/pj/article/view/280